Huixin Lifetech

Huixin Lifetech, founded by renowned scientists and industry experts in the exosome field, is committed to developing world-leading biotechnologies and products to advance the application of exosomes in cancer diagnosis and cell therapy. The company focuses on creating cutting-edge biomedical technologies and products. Driven by real-world needs, Huixin Lifetech consistently adheres to the principles that "science and technology are the primary productive forces, talent is the foremost resource, and innovation is the primary driving force." It strives to enhance the market competitiveness of its products and services, meeting the diverse demands of scientific research and clinical translation. The company continuously improves the automation and intelligence of its products to overcome key bottleneck technologies in the fields of exosome diagnostics and treatment. Its core team has extensive experience in academic research, product development, and market expansion. Leveraging their deep expertise in medical device development, they launched EXODUS®, the world’s first label-free automated purification system for exosome isolation and purification. Additionally, based on their advanced exosome purification technology platform, Huixin Lifetech has made significant progress in areas such as the development of diagnostic kits for urological tumors and the large-scale preparation of stem cell-derived exosomes.